Share Twitter LinkedIn Facebook Email Amrita Krishnan MD FACP of The Judy and Bernard Briskin Center for Multiple Myeloma Research discusses the updates at ASH 2017 of the treatment of multiple myeloma at the 2018 MOASC Spotlight on Hematology meeting in Huntington Beach, CA.
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read